Page 134 - 73_04

ESTHER VICENTE Y COLS. ANAL. REAL ACAD. NAC. FARM.

(24) ORTEGA, M. A.; MONTOYA, M. E.; JASO, A.; ZARRANZ, B.; TIRAPU, I.; ALDANA, I. Y
MONGE, A. (2001) Antimycobacterial activity of new quinoxaline-2-carbonitri-
(25) le and quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives. Pharmazie. 56:
205-207.
(26) ORTEGA, M. A.; SAINZ, Y.; MONTOYA, M. E.; JASO, A.; ZARRANZ, B.; ALDANA, I. Y
(27) MONGE, A. (2002) Anti-Mycobacterium tuberculosis agents derived from qui-
(28) noxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide. Arz-
(29) neim.-Forsch. 52: 113-119.
ZARRANZ, B.; JASO, A.; ALDANA, I. Y MONGE, A. (2003) Synthesis and antimyco-
(30) bacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivati-
(31) ves. Bioorg. Med. Chem. 11: 2149-2156.
(32) JASO, A.; ZARRANZ, B.; ALDANA, I. Y MONGE, A. (2003) Synthesis of new 2-acetyl
(33) and 2-benzoyl quinoxaline 1,4-di-N-oxide derivatives as anti-Mycobacterium
tuberculosis agents. Eur. J. Med. Chem. 38: 791-800.
(34) JASO, A.; ZARRANZ, B.; ALDANA, I. Y MONGE, A. (2005) Synthesis of new quinoxa-
(35) line-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis
(36) agents. J. Med. Chem. 48: 2019-2025.
(37) GUILLON, J.; REYNOLDS, R. C.; LEGER, J. M.; GUIE, M. A.; MASSIP, S.; DALLEMAGNE,
P. Y JARRY, C. (2004) Synthesis and preliminary in vitro evaluation of anti-
mycobacterial activity of new pyrrolo[1,2-a]quinoxaline-carboxylic acid
hydrazide derivatives. J. Enzyme Inhib. Med. Chem. 19: 489-495.
KUNES, J.; SPULAK, M.; WAISSER, K.; SLOSAREK, M. Y JANOTA, J. (2000) Quinoxa-
line derivatives as potential antituberculotic agents. Pharmazie. 55: 858-859.
SEITZ, L. E.; SULING, W. J. Y REYNOLDS, R. C. (2002) Synthesis and antimyco-
bacterial activity of pyrazine and quinoxaline derivatives. J. Med. Chem. 45:
5604-5606.
CARTA, A.; PAGLIETTI, G.; RAHBAR NIKOOKAR, M. E.; SANNA, P.; SECHI, L. Y ZANETTI,
S. (2002) Novel substituted quinoxaline 1,4-dioxides with in vitro antimyco-
bacterial and anticandida activity. Eur. J. Med. Chem. 37: 355-366.
GOLDMAN, R. C.; LAUGHON, B. E.; REYNOLDS, R. C.; SECRIST, J. A.; MADDRY, J. A.;
GUIE, M. A.; POFFENBERGER, A. C.; KWONG, C. A. Y ANANTHAN, S. (2007) Progra-
ms to Facilitate Tuberculosis Drug Discovery: The Tuberculosis Antimicro-
bial Acquisition and Coordinating Facility. Infectious Disorders - Drug Targets
(Formerly Current Drug Targets – Infectious). 7: 92-104.
FISHER, G. H.; MORENO, H. R.; OATIS, J. E. Y SCHULTZ, H. P. (1975) Quinoxaline
Studies. 23. Potential Antimalarials - Substituted 5,8-dimethoxyquinoxalines.
J. Med. Chem. 18: 746-752.
MORENO, H. R. Y SCHULTZ, H. P. (1970) Quinoxaline Studies. 15. Potential
Antimalarials. Some (RS)-Alpha(Dialkylaminomethyl)-2-Quinoxalinemetha-
nols. J. Med. Chem. 13: 119-121.
MORENO, H. R. Y SCHULTZ, H. P. (1970) Quinoxaline Studies. 17. Potential
Antimalarials. 17. Some (RS)-Alpha-(Dialkylaminomethyl)-6-Chloro-2-Qui-
noxalinemethanols. J. Med. Chem. 13: 1005-1008.
MORENO, H. R.; SCHULTZ, H. P. Y OATIS, J. E. (1972) Quinoxaline Studies. 20.
Potential Antimalarials - Synthesis of Anti-N,N-Dialkylaminomethyl and Syn-
N,N-Dialkylaminomethyl 2-Quinoxalinyl Ketoximes. J. Med. Chem. 15: 433-
434.

944